CSIMarket
 
Accelerate Diagnostics Inc   (NASDAQ: AXDX)
 

Accelerate Diagnostics Inc's Customers Performance

AXDX



 
AXDX's Source of Revenues During the corresponding time, Accelerate Diagnostics Inc saw a revenue deteriorated by -6.97 % year on year, sequentially revenue fell by -1.4 %. While revenue at the Accelerate Diagnostics Inc 's corporate clients

List of AXDX Customers




for the same period Accelerate Diagnostics Inc revnue deteriorated by -6.97 % year on year, sequentially revenue fell by -1.4 %.

List of AXDX Customers

Accelerate Diagnostics Inc's Business Units
Domestic    95.24 % of total Revenue
Foreign    8.93 % of total Revenue
Products    91.7 % of total Revenue
Services    12.46 % of total Revenue






Accelerate Diagnostics Inc's Comment on Sales, Marketing and Customers



The Accelerate WAVE system is designed for the global microbiology laboratory market to provide rapid antimicrobial susceptibility testing (AST). It addresses the need for faster AST results to combat sepsis and antibiotic resistance. The system supports high laboratory volumes by testing multiple assays per module and can scale up to five modules per system. Its primary customers are clinical microbiology laboratories that perform AST to identify effective antibiotics for patient infections. The system aims to reduce the time required to deliver AST results from days to hours. Target markets include hospitals and healthcare providers managing sepsis and hospital-acquired infections, particularly in the United States, where antibiotic resistance and such infections are significant concerns.





Accelerate Diagnostics Inc’s Comment on Sales, Marketing and Customers


The Accelerate WAVE system is designed for the global microbiology laboratory market to provide rapid antimicrobial susceptibility testing (AST). It addresses the need for faster AST results to combat sepsis and antibiotic resistance. The system supports high laboratory volumes by testing multiple assays per module and can scale up to five modules per system. Its primary customers are clinical microbiology laboratories that perform AST to identify effective antibiotics for patient infections. The system aims to reduce the time required to deliver AST results from days to hours. Target markets include hospitals and healthcare providers managing sepsis and hospital-acquired infections, particularly in the United States, where antibiotic resistance and such infections are significant concerns.








AXDX's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Accelerate Diagnostics Inc 0.79 10.70 -50.05 134
SUBTOTAL 0.00 0.00 0.00 -

Sources: Accelerate Diagnostics Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Accelerate Diagnostics Inc’s corporate clients.
For your research, we’ve provided 9 tables on Accelerate Diagnostics Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.